Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |